Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Bolster

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bailliere'S Clinical Rheumatology|February 1, 1993
Lung disease in systemic sclerosis (scleroderma)M B Bolster, R M Silver
Clinical and Experimental Rheumatology|April 4, 2003
Scleroderma renal crisis in pregnancy associated with massive proteinuriaA N Brown, M B Bolster
Current Opinion in Rheumatology|November 7, 1999
Assessment and management of scleroderma lung diseaseM B Bolster, R M Silver
Current Opinion in Rheumatology|November 1, 1994
Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophiliaM B Bolster, R M Silver
The Medical Clinics of North America|January 1, 1997
Scleroderma and related conditionsH Mitchell, M B Bolster, E C LeRoy
Cleveland Clinic Journal of Medicine|January 1, 1995
Office evaluation and treatment of Raynaud's phenomenonM B Bolster, H R Maricq, R L Leff
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 6, 2001
Carpal tunnel syndrome in sarcoidosisG W Niemer, M B Bolster, L Buxbaum, et al.
Neurotoxicology and Teratology|September 1, 1996
Cognitive deficits in a murine model of the eosinophilia-myalgia syndrome: a preliminary reportL D Middaugh, R Nussbaum, A Ludwicka, et al.
Arthritis and Rheumatism|April 1, 1997
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosisM B Bolster, A Ludwicka, S E Sutherland, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parametersA Fischer, J J Swigris, M B Bolster, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bailliere'S Clinical Rheumatology|February 1, 1993
Lung disease in systemic sclerosis (scleroderma)M B Bolster, R M Silver
Clinical and Experimental Rheumatology|April 4, 2003
Scleroderma renal crisis in pregnancy associated with massive proteinuriaA N Brown, M B Bolster
Current Opinion in Rheumatology|November 7, 1999
Assessment and management of scleroderma lung diseaseM B Bolster, R M Silver
Current Opinion in Rheumatology|November 1, 1994
Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophiliaM B Bolster, R M Silver
The Medical Clinics of North America|January 1, 1997
Scleroderma and related conditionsH Mitchell, M B Bolster, E C LeRoy
Cleveland Clinic Journal of Medicine|January 1, 1995
Office evaluation and treatment of Raynaud's phenomenonM B Bolster, H R Maricq, R L Leff
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 6, 2001
Carpal tunnel syndrome in sarcoidosisG W Niemer, M B Bolster, L Buxbaum, et al.
Neurotoxicology and Teratology|September 1, 1996
Cognitive deficits in a murine model of the eosinophilia-myalgia syndrome: a preliminary reportL D Middaugh, R Nussbaum, A Ludwicka, et al.
Arthritis and Rheumatism|April 1, 1997
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosisM B Bolster, A Ludwicka, S E Sutherland, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parametersA Fischer, J J Swigris, M B Bolster, et al.
Pageof 2